Document:

EX-10.22

 Exhibit 10.22 

Ortho Clinical Diagnostics 
  

 
  

 Chockalingam Palaniappan 

San Diego, California 
 Dear Palani: 

The purpose of this letter is to confirm Ortho’s intent to provide you with an Enhanced Minimum Severance, based on your role as Chief Innovation Officer.

 This is to confirm that we approve a minimum severance for you, should the need present itself, of twelve (12) months of your base salary. The
Company will also subsidize the cost of your COBRA coverage for the same period of time (based on the current policy). Your portion of the cost of that coverage will be the same amount paid by other similarly situated active employees and will be
deducted from your severance pay on a pre-tax basis. This period of subsidized coverage is considered part of your COBRA Continuation Coverage. 

This minimum of 12 months will apply regardless of Ortho’s actual severance policy in place at the time of separation, provided the termination is not
for cause nor due to individual performance. All other terms and conditions of the in-force Severance Pay Policy will apply, including the requirement to enter into a Separation Agreement and Release, in a
form satisfactory to the Employer Company, by executing such Agreement and Release and having the Agreement and Release become effective. 
 Note that upon
hire, your home location is Denver. In the future, to the extent that your position is required to relocate greater than 50 miles, that would trigger severance eligibility in the event you are not willing to relocate. 

If you have any further questions, please contact me at 908-704-6883. 

Sincerely, 
  

	
	 /s/ Gary Passman

	Gary Passman
	Head of Global People & Culture

  
 Ortho Clinical Diagnostics | 1001 US Route
202 Raritan, NJ 08869-0606EX-10.23

 Exhibit 10.23 

Execution Version 

Employment Agreement 

This Employment Agreement (this “Agreement”), dated as of May 22, 2014, is made by and between Crimson Bermuda Co. a Bermuda
exempted limited liability company (together with any successor thereto, the “Company”) and MICHAEL A. SCHLESINGER (the “Executive”) (collectively referred to herein as the
“Parties”). 
 RECITALS 
  

	A.	 It is the desire of the Company to assure itself of the services of Executive effective as of the Effective
Date and thereafter by entering into this Agreement. 

  

	B.	 Executive and the Company mutually desire that Executive provide services to the Company on the terms herein
provided. 

 AGREEMENT 

NOW, THEREFORE, in consideration of the foregoing and of the respective covenants and agreements set forth below, the Parties hereto agree as
follows; 
  

	1.	 Employment. 

(a) General. Effective as of the closing of the acquisition of the first part of the Ortho-Clinical Diagnostics, Inc. business by the
Company from Johnson & Johnson pursuant to the Stock and Asset Purchase Agreement dated January 16, 2014 (the “Effective Date”), the Company shall employ Executive and Executive shall remain in the employ of the
Company, for the period and in the position set forth in this Section 1, and subject to the other terms and conditions herein provided. In the event the above-mentioned closing does not occur for any reason, this Agreement shall not
become effective and shall be null and void and of no force or effect. 
 (b) Employment Term. The term of employment under this
Agreement (the “Term”) shall be for the period beginning on the Effective Date, and ending on the December 31, 2016, subject to earlier termination as provided in Section 3. The Term shall automatically renew for
additional twelve (12) month periods unless no later than sixty (60) days prior to the end of the applicable Term either party gives written notice of non-renewal (“Notice of
Non-Renewal”) to the other, in which case Executive’s employment will terminate at the and of the then-applicable Term, subject to earlier termination as provided in Section 3. 

(c) Position and Duties. Executive shall serve as the Senior Vice President, General Counsel and Secretary of the Company with such
responsibilities, duties and authority normally associated with such positions and as may from time to time be assigned to Executive by the Board of Directors of the Company or an authorized committee (in any case, the “Board”) or
the Company’s Chief Executive Officer. Executive shall devote substantially all of Executive’s working time and efforts to the business and affairs of the Company (which shall include service to its affiliates) and shall not engage in
outside business activities (including serving on outside boards or committees) without the consent of the Board, provided that Executive shall be permitted to (i) manage Executive’s personal, financial and legal affairs,
(ii) participate in trade associations, (iii) serve on the board of directors of not-for-profit or tax-exempt charitable
organizations, and (iv) with Board approval, serve on the board of directors or similar board of for-profit organizations, in each case, subject to compliance with this Agreement and provided that such
activities do not materially interfere with Executive’s performance of Executive’s duties and responsibilities hereunder. Executive agrees to observe and comply with the rules and policies of the Company and its subsidiaries as adopted by
the Company or its affiliates from time to time, in each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a “Policy”). 

 (d) Principal Place of Employment. Executive’s principal place of employment
shall be the Company’s headquarters in the United States, although Executive understands and agrees that Executive will be required to travel from time to time for business reasons. 

 

	2.	 Compensation and Related Matters. 

(a) Annual Base Salary. During the Term, Executive shall receive a base salary at a rate of $450,000 per annum, which shall be paid in
accordance with the customary payroll practices of the Company and shall be pro-rated for partial years of employment. Such annual base salary shall be reviewed at least annually and may be adjusted from time to time by the Board (such annual base
salary, as it may be adjusted from time to time, the “Annual Base Salary”). 
 (b) Bonus. 

(i) During the Term, Executive will be eligible to participate in an annual incentive program established by the Board.
Executive’s annual incentive compensation under such incentive program (the “Annual Bonus”) shall be targeted at 50% of his Annual Base Salary (the “Target Bonus”), with the expectation that the bonus will
scale upward and downward based on actual performance, as determined by the Board, such that the actual Annual Bonus payable to Executive may be greater than, equal to or less than the Target Bonus. The Annual Bonus shall initially be based 80% upon
the achievement of Company performance metrics established by the Board (initially expected to be 50% based on Company EBITDA performance and 30% based on Company revenue performance) and 20% upon achievement of individual qualitative factors as
determined by the Board in its discretion. The Annual Bonus for fiscal year 2014 will be pro-rated based on the length of Executive’s employment with the Company during such year. The payment of any Annual Bonus pursuant to the incentive
program shall be subject to Executive’s continued employment with the Company through the date of payment; provided however that if Executive’s employment shall terminate (other than as a result of the Company’s termination of the
Executive’s employment for Cause pursuant to Section 3(a)(iii) or as a result of the Executive’s resignation without Good Reason pursuant to Section 3(a)(vi)) on or after the first day of an applicable fiscal year, Executive
shall be entitled to receive any earned but unpaid Annual Bonus for the prior fiscal year pursuant to this Section 2(b). For the first twelve months of the Term, Executive shall receive an advance against his Annual Bonus in an amount at
annualized rate of $50,000 (the “Bonus Advance”), which Bonus Advance will be payable in equal installments in accordance with the Company’s regular payroll pay practices over such twelve month period and will reduce on a
dollar for dollar basis his Annual Bonus for the applicable year. As an illustration, if the Effective Date is July 1, 2014, Executive will receive periodic Bonus Advance payments totaling $25,000 for calendar year 2014 (which amount shall be
recouped from Executive’s 2014 Annual Bonus) and $25,000 for calendar year 2015 (which amount shall be recouped from Executive’s 2015 Annual Bonus). In the event Executive does not earn an Annual Bonus for an applicable calendar year
sufficient to recoup the Bonus Advance, Executive shall repay such un-recouped amounts promptly to the Company. 

(ii) Executive will receive a one-time special cash
“sign-on” bonus of $60,000, payable as soon as practicable after the Effective Time (the “Sign-on Bonus”). If the Executive’s employment
shall terminate as a result of the Company’s termination of the Executive’s employment for Cause pursuant to Section 3(a)(iii) or, prior to the 5th anniversary of the Effective
Date, as a result of the Executive’s resignation without Good Reason pursuant to Section 3(a)(vi)), the Executive shall be required to repay the Sign-on Bonus to the Company. The Sign-On Bonus shall
be in lieu of any reimbursements or benefits in relation to relocation, temporary living or similar costs or expenses. 

  
 2 

 (c) Equity Compensation: Investment. As soon as reasonably practicable following the
Effective Date, Executive will be granted an option (the “Options”) to purchase 315,789 common shares of the Company (which number assumes the Initial Price Per Share is $10.00), pursuant to the terms of an equity incentive plan and
stock option agreement that will be established by the Company (the “Equity Plan”). The per share exercise prices of the Options shall be the same as the per share price paid by the Company’s principal stockholders
(collectively, “Carlyle”) in connection with the acquisition (the “Initial Price Per Share”). The Options will have a 10 year term, subject to earlier termination in the event of a termination of employment or in
the event of certain corporate or other extraordinary transaction or occurrences, in each case in accordance with the terms of the Equity Plan and the stock option agreement pursuant to which such Options will be granted. In addition, Executive will
have the opportunity to further invest in the Company through the purchase of vested common shares of the Company. The shares underlying the Options and the shares purchased pursuant to the investment shall be subject to a call right upon
termination of employment and the underlying shares shall be subject to standard restrictions and drag and tag along provisions. The Options will vest as set forth in the stock option agreement (subject to continued employment on the applicable
vesting date), which vesting is summarized below: 
 (i) 60% of the Options will be eligible to vest in five (5) equal
annual installments, subject to acceleration upon a “Liquidity Event,” which will generally be defined as a sale of 70% of Carlyle’s initial investment; 

(ii) 40% of the Options will be eligible to vest based on achievement of EBITDA targets over five (5) fiscal years
(“Performance Options”). Upon a Liquidity Event, Performance Options otherwise scheduled to vest after the Liquidity Event date shall accelerate if Carlyle’s initial investment results in the attainment of a 20% IRR and 2.0x
MOIC. 
 (d) Benefits. During the Term, Executive shall be eligible to participate in employee benefit plans, programs and
arrangements maintained for senior executives of the Company (including medical, dental and 401(k) plans), consistent with the terms thereof and as such plans, programs and arrangements may be amended from time to time. In no event shall Executive
be eligible to participate in any severance plan or program of the Company, except as set forth in Section 4 of this Agreement. 
 (e)
Vacation. During the Term, Executive shall be entitled to at least twenty (20) days on an annualized basis of paid personal leave in accordance with the Company’s Policies. Any vacation shall be taken at the reasonable and mutual
convenience of the Company and Executive. 
 (f) Business Expenses. During the Term, the Company shall reimburse Executive for all
reasonable travel and other business expenses incurred by Executive in the performance of Executive’s duties to the Company in accordance with the Company’s expense reimbursement Policy. 

(g) Indemnification. During and after the Term, the Company shall provide the Executive with no less favorable directors’ and
officers’ liability insurance and indemnification and advancement rights than apply to any then-current officer or director of Company. 

  
 3 

 (h) Key Person Insurance. At any time during the Term, the Company shall have the
right to insure the life of Executive for the Company’s sole benefit. The Company shall have the right to determine the amount of insurance and the type of policy. Executive shall reasonably cooperate with the Company in obtaining such
insurance by submitting to physical examinations, by supplying all information reasonably required by any insurance carrier, and by executing all necessary documents reasonably required by any insurance carrier, provided that any information
provided to an insurance company or broker shall not be provided to the Company without the prior written authorization of Executive. Executive shall incur no financial obligation by executing any required document, and shall have no interest in any
such policy. 
  

	3.	 Termination. 

Executive’s employment hereunder may be terminated by the Company or Executive, as applicable, without any breach of this Agreement under
the following circumstances: 
 (a) Circumstances. 

(i) Death. Executive’s employment hereunder shall terminate upon Executive’s death. 

(ii) Disability. If Executive has incurred a Disability, as defined below, the Company may terminate Executive’s
employment. 
 (iii) Termination for Cause. The Company may terminate Executive’s employment for Cause, as
defined below. 
 (iv) Termination without Cause. The Company may terminate Executive’s employment without Cause,
which shall include a termination of Executive as a result of the Company not renewing the Term pursuant to Section 1. 

(v) Resignation from the Company for Good Reason. Executive may resign Executive’s employment with the Company for
Good Reason, as defined below. 
 (vi) Resignation from the Company Without Good Reason. Executive may resign
Executive’s employment with the Company for any reason other than Good Reason or for no reason, which shall include a termination of Executive as a result of Executive not renewing the Term pursuant to Section 1. 

(b) Notice of Termination. Any termination of Executive’s employment by the Company or by Executive under this
Section 3 (other than termination pursuant to paragraph (a)(i)) shall be communicated by a written notice to the other party hereto (i) indicating the specific termination provision in this Agreement relied upon,
(ii) setting forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated, if applicable, and (iii) specifying a Date of Termination
which, if submitted by Executive, shall be at least forty-five (45) days following the date of such notice (a “Notice of Termination”); provided, however, that in the event that Executive delivers a Notice of Termination
to the Company, the Company may, in its sole discretion, change the Date of Termination to any date that occurs following the date of Company’s receipt of such Notice of Termination and is prior to the date specified in such Notice of
Termination. A Notice of Termination submitted by the Company may provide for a Date of Termination on the date Executive receives the Notice of Termination, or any date within 45 days thereafter as determined by the Company in its sole discretion.
The failure by the Company or Executive to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Cause or Good Reason shall not waive any right of such Party hereunder or preclude such Party from asserting
such fact or circumstance in enforcing such Party’s rights hereunder. 

  
 4 

 (c) Company Obligations upon Termination. Upon termination of Executive’s
employment pursuant to any of the circumstances listed in Section 3. Executive (or Executive’s estate) shall be entitled to receive the sum of: (i) the portion of Executive’s Annual Base Salary earned through
the Date of Termination, but not yet paid to Executive; (ii) any vacation time that has been accrued but unused in accordance with Company’s Policies, (iii) any reimbursements owed to Executive pursuant to Section 2(f); and
(iv) any amount accrued and arising from Executive’s participation in, or benefits accrued under any employee benefit plans, programs or arrangements, which amounts shall be payable in accordance with the terms and conditions of such
employee benefit plans, programs or arrangements (collectively, the “Company Arrangements”). Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Executive’s rights to
salary, severance, benefits, bonuses and other compensatory amounts hereunder (if any) shall cease upon the termination of Executive’s employment hereunder. In the event that Executive’s employment is terminated by the Company for any
reason, Executive’s sole and exclusive remedy shall be to receive the payments and benefits described in this Section 3(c) or Section 4, as applicable. 

(d) Deemed Resignation. Upon termination of Executive’s employment for any reason. Executive shall be deemed to have resigned from
all offices and directorships, if any, then held with the Company or any of its affiliates. 
  

	4.	 Severance Payments. 

(a) Termination for Cause, or Termination Upon Death. Disability or Resignation from the Company Without Good Reason. If
Executive’s employment shall terminate as a result of Executive’s death pursuant to Section 3(a)(i) or Disability pursuant to Section 3(a)(ii), pursuant to
Section 3(a)(iii) for Cause, or pursuant to Section 3(a)(vi) for Executive’s resignation from the Company without Good Reason, then Executive shall not be entitled to any severance payments or
benefits, except as provided in Section 3(c). 
 (b) Termination without Cause, or Resignation from the Company for Good Reason.
If Executive’s employment terminates without Cause pursuant to Section 3(a)(iv) (including a termination of Executive as a result of the Company not renewing the Term pursuant to Section 1), or pursuant to
Section 3(a)(v) due to Executive’s resignation for Good Reason, then, subject to Executive signing on or before the 21st day following Executive’s Separation
from Service (as defined below), and not revoking, a release of claims substantially in the form attached as Exhibit A to this Agreement (the “Release”), and Executive’s continued compliance with Sections 5 and 6,
Executive shall receive, in addition to payments and benefits set forth in Section 3(c), the following. 
 (i) an amount
in cash equal to 1.25 times the Annual Base Salary plus 1.25 times the Target Bonus, payable in the form of salary continuation in regular installments over the 15-month period following the date of
Executive’s Separation from Service (the “Severance Period”) in accordance with the Company’s normal payroll practices; and 

(ii) payment in an amount equal to the amount of the premiums Executive would be required to pay to continue Executive’s
and Executive’s covered dependents’ medical, dental and vision coverage in effect on the Date of Termination under the Company’s group healthcare plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended
(“COBRA”), which amount shall be based on the premium for the first month of COBRA coverage and shall be paid on the Company’s first regular pay date of each calendar month during the period commencing on Executive’s
Separation from Service and ending upon the earliest of (A) the last day of the Severance Period, or (B) the date Executive becomes eligible to receive healthcare coverage from a subsequent employer. 

  
 5 

 (c) Mitigation and Set Off. In order to be eligible to receive the benefits of this
Section 4, Executive shall have no duty to mitigate and no compensation or benefits, if any, received by him or his dependents from third parties during the Severance Period shall be set off against any amounts or benefits payable pursuant to
this Section 4. 
 (c) Survival. Notwithstanding anything to the contrary in this Agreement, the provisions of Sections
5 through 9 and Section 11 will survive the termination of Executive’s employment and the expiration or termination of the Term. 

5. Competition. Executive acknowledges that Executive has been provided with Confidential Information (as defined below) and during the Term, the
Company from time to time will provide Executive with access to Confidential Information. Ancillary to the rights provided to Executive as set forth in this Agreement and the Company’s provision of Confidential Information, and Executive’s
agreements regarding the use of same, in order to protect the value of any Confidential Information, the Company and Executive agree to the following provisions against unfair competition, which Executive acknowledges represent a fair balance of the
Company’s rights to protect its business and Executive’s right to pursue employment: 
 (a) Executive shall not, at any time during
the Restriction Period (as defined below), directly or indirectly engage in, have any equity interest in, interview for a potential employment or consulting relationship with or manage, provide services to or operate any person, firm, corporation,
partnership or business (whether as director, officer, employee, agent, representative, partner, security holder, consultant or otherwise) that engages in any business which competes with any portion of the Business (as defined below) of the Company
anywhere in the world. Nothing herein shall prohibit Executive from practicing law or being a passive owner of not more than 2% of the outstanding equity interest in any entity that is publicly traded, so long as Executive has no active
participation in the business of such entity. 
 (b) Executive shall not, at any time during the Restriction Period, directly or indirectly,
(i) solicit, divert or take away any customers, clients, or business acquisition or other business opportunity of the Company, (ii) contact or solicit, with respect to hiring, or hire any employee of the Company or any person employed by
the Company at any time during the 12-month period immediately preceding the Date of Termination, (iii) induce or otherwise counsel, advise or encourage any employee of the Company to leave the employment
of the Company, or (iv) induce any distributor, representative or agent of the Company to terminate or modify its relationship with the Company. 

(c) In the event the terms of this Section 5 shall be determined by any court of competent jurisdiction to be
unenforceable by reason of its extending for too great a period of time or over too great a geographical area or by reason of its being too extensive in any other respect, it will be interpreted to extend only over the maximum period of time for
which it may be enforceable, over the maximum geographical area as to which it may be enforceable, or to the maximum extent in all other respects as to which it may be enforceable, all as determined by such court in such action. 

(d) As used in this Section 5. (i) the term “Company” shall include the Company and its direct and indirect
parents and subsidiaries; (ii) the term “Business” shall mean the business of the Company and shall include the research, development, design, manufacturing, marketing, distribution and selling of
(a) in-vitro diagnostics products, and providing services with respect thereto, in the fields of clinical laboratories, immunohematology, blood donor screening, point of care diagnostics and veterinary
clinical chemistry, or (b) any other process, system, product or service marketed, sold or under development by the Company at any time during Executive’s employment with the Company; and (iii) the term “Restriction
Period” shall mean the period beginning on the Effective Date and ending on the date 12 months following the Date of Termination. 

  
 6 

 (e) Executive represents that Executive’s employment by the Company does not and will
not breach any agreement with any former employer, including any non-compete agreement or any agreement to keep in confidence or refrain from using information acquired by Executive prior to Executive’s
employment by the Company. During Executive’s employment by the Company, Executive agrees that Executive will not violate any non-solicitation agreements that Executive entered into with any former
employer or improperly make use of, or disclose, any information or trade secrets of any former employer or other third party, nor will Executive bring onto the premises of the Company or its affiliates or use any unpublished documents or any
property belonging to any former employer or other third party, in violation of any lawful agreements with that former employer or third party. 

(f) Each Party (which, in the case of the Company, shall mean its officers and the members of the Board) agrees, during the Term and following
the Date of Termination, to refrain from Disparaging (as defined below) the other Party and its affiliates, including, in the case of the Company, any of its services, technologies or practices, or any of its directors, officers, agents,
representatives or stockholders, either orally or in writing. Nothing in this paragraph shall preclude any Party from making truthful statements that are reasonably necessary to comply with applicable law, regulation or legal process, or to defend
or enforce a Party’s rights under this Agreement. For purposes of this Agreement, “Disparaging” means making remarks, comments or statements, whether written or oral, that impugn the character, integrity, reputation or abilities of
the Person being disparaged. 
  

	6.	 Nondisclosure of Proprietary Information. 

(a) Except in connection with the faithful performance of Executive’s duties hereunder or pursuant to Section 6(c) and (e),
Executive shall, in perpetuity, maintain in confidence and shall not directly, indirectly or otherwise, use, disseminate, disclose or publish, or use for Executive’s benefit or the benefit of any person, firm, corporation or other entity (other
than the Company) any confidential or proprietary information or trade secrets of or relating to the Company (including, without limitation, business plans, business strategies and methods, acquisition targets, intellectual property in the form of
patents, trademarks and copyrights and applications therefor, ideas, inventions, works, discoveries, improvements, information, documents, formulae, practices, processes, methods, developments, source code, modifications, technology, techniques,
data, programs, other know-how or materials, owned, developed or possessed by the Company, whether in tangible or intangible form, information with respect to the Company’s operations, processes,
products, inventions, business practices, finances, principals, vendors, suppliers, customers, potential customers, marketing methods, costs, prices, contractual relationships, regulatory status, prospects and compensation paid to employees or other
terms of employment) (collectively, the “Confidential Information”), or deliver to any person, firm, corporation or other entity any document, record, notebook, computer program or similar repository of or containing any such
Confidential Information. The Parties hereby stipulate and agree that, as between them, any item of Confidential Information is important, material and confidential and affects the successful conduct of the businesses of the Company (and any
successor or assignee of the Company). Notwithstanding the foregoing, Confidential Information shall not include any information that has been published in a form generally available to the public or is publicly available or has become public
knowledge prior to the date Executive proposes to disclose or use such information, provided, that such publishing or public availability or knowledge of the Confidential Information shall not have resulted from Executive directly or
indirectly breaching Executive’s obligations under this Section 6(a) or any other similar provision by which Executive is bound, or from any third-party breaching a provision similar to that found under this
Section 6(a). For the purposes of the previous sentence, Confidential Information will not be deemed to have been published or otherwise disclosed merely because individual portions of the information have been separately
published, but only if material features comprising such information have been published or become publicly available. 

  
 7 

 (b) Upon termination of Executive’s employment with the Company for any reason,
Executive will promptly deliver to the Company all correspondence, drawings, manuals, letters, notes, notebooks, reports, programs, plans, proposals, financial documents, or any other documents or property concerning the Company’s customers,
business plans, marketing strategies, products, property or processes. 
 (c) Executive may respond to a lawful and valid subpoena or other
legal process but shall give the Company the earliest possible notice thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other information sought and shall assist such
counsel at Company’s expense in resisting or otherwise responding to such process, in each case to the extent permitted by applicable laws or rules. 

(d) As used in this Section 6 and Section 7, the term “Company” shall
include the Company and its direct and indirect parents and subsidiaries. 
 (e) Nothing in this Agreement shall prohibit Executive from
(i) disclosing information and documents when required by law, subpoena or court order (subject to the requirements of Section 6(c) above), (ii) disclosing information and documents to Executive’s attorney,
financial or tax adviser for the purpose of securing legal, financial or tax advice, (iii) disclosing Executive’s post-employment restrictions in this Agreement in confidence to any potential new employer, or (iv) retaining, at any time,
Executive’s personal correspondence, Executive’s personal contacts and documents related to Executive’s own personal benefits, entitlements and obligations. 
  

	7.	 Inventions. 

All rights to discoveries, inventions, improvements and innovations (including all data and records pertaining thereto) related to the
Business, whether or not patentable, copyrightable, registrable as a trademark, or reduced to writing, that Executive may discover, invent or originate during the Term, either alone or with others and whether or not during working hours or by the
use of the facilities of the Company (“Inventions"), shall be the exclusive property of the Company. Executive shell promptly disclose all Inventions to the Company, shall execute at the request of the Company any assignments or other
documents the Company may deem reasonably necessary to protect or perfect its rights therein, and shall assist the Company, upon reasonable request and at the Company’s expense, in obtaining, defending and enforcing the Company’s rights
therein. Executive hereby appoints the Company as Executive’s attorney-in-fact to execute on Executive’s behalf any assignments or other documents reasonably
deemed necessary by the Company to protect or perfect its rights to any Inventions. 
  

	8.	 Injunctive Relief. 

It is recognized and acknowledged by Executive that a breach of the covenants contained in Sections 5, 6 and 7 will cause irreparable
damage to Company and its goodwill, the exact amount of which will be difficult or impossible to ascertain, and that the remedies at law for any such breach will be inadequate. Accordingly, Executive agrees that in the event of a breach of any of
the covenants contained in Sections 5, 6 and 7, in addition to any other remedy which may be available at law or in equity, the Company will be entitled to specific performance and injunctive relief without the requirement to post bond. 

  
 8 

	9.	 Assignment and Successors. 

The Company may assign its rights and obligations under this Agreement to a United States subsidiary of the Company that is the main operating
company of the Company in the United States (provided that Executive shall also hold the position stated in Section 1(o) with Crimson Bermuda Co. Ltd. while employed by such subsidiary) or to any successor to all or substantially all of the
business or the assets of the Company (by merger or otherwise), and may assign or encumber this Agreement and its rights hereunder as security for indebtedness of the Company and its affiliates, This Agreement shall be binding upon and inure to the
benefit of the Company, Executive and their respective successors, assigns, personnel and legal representatives, executors, administrators, heirs, distributees, devisees, and legatees, as applicable. None of Executive’s rights or obligations
may be assigned or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only by will or operation of law. Notwithstanding the foregoing, Executive shall be entitled, to the extent permitted
under applicable law and applicable Company Arrangements, to select and change a beneficiary or beneficiaries to receive compensation hereunder following Executive’s death by giving written notice thereof to the Company. 

 

	10.	 Certain Definitions. 

(a) Cause. The Company shall have “Cause” to terminate Executive’s employment hereunder upon: 

(i) Executive’s failure to (A) substantially perform his duties with the Company (other than any such failure
resulting from Executive’s Disability) or (B) comply with, in any material respect, any of the Company’s Policies; 

(ii) the Board’s determination that Executive failed in any material respect to carry out or comply with any lawful and
reasonable directive of the Board; 
 (iii) Executive’s breach of a material provision of this Agreement; 

(iv) Executive’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated
probation for any felony or crime involving moral turpitude; 
 (v) Executive’s unlawful use (including being under the
influence) or possession of illegal drugs on the Company’s (or any of its affiliate’s) premises or while performing Executive’s duties and responsibilities under this Agreement; or 

(vi) Executive’s commission of an act of fraud, embezzlement, misappropriation, willful misconduct, or breach of fiduciary
duty against the Company or any of its affiliates. 
 Notwithstanding the foregoing, clauses (i) – (iii) shall not constitute
“Cause” unless and until the Company has: (a) provided Executive, within 60 days of any Company director’s knowledge of the occurrence of the facts end circumstances underlying such Cause event, written-notice stating with
specificity the applicable facts and circumstances underlying such finding of Cause; and (b) provided the Executive with an opportunity to cure the same within 30 days after the receipt of such notice. 

(b) Date of Termination. “Date of Termination” shall mean (i) if Executive’s employment is terminated by
Executive’s death, the date of Executive’s death; (ii) if Executive’s employment is terminated pursuant to Section 3(a)(ii) – (vi) either the date indicated in the Notice of Termination or the date specified by
the Company pursuant to Section 3(b), whichever is earlier. 

  
 9 

 (c) Disability. “Disability” shall mean, at any time the Company or any of
its affiliates sponsors a long-term disability plan for the Company’s employees, “disability” as defined in such long-term disability plan for the purpose of determining a participant’s eligibility for benefits, provided,
however, if the long-term disability plan contains multiple definitions of disability, “Disability” shall refer to that definition of disability which, if Executive qualified for such disability benefits, would provide coverage for the
longest period of time. The determination of whether Executive has a Disability shall be made by the person or persons required to make disability determinations under the long-term disability plan. At any time the Company does not sponsor a
long-term disability plan for its employees, Disability shall mean Executive’s inability to perform, with or without reasonable accommodation, the essential functions of Executive’s position hereunder for a total of three months during any
six-month period as a result of incapacity due to mental or physical illness as determined by a physician selected by the Company or its insurers and acceptable to Executive or Executive’s legal
representative, with such agreement as to acceptability not to be unreasonably withheld or delayed. Any refusal by Executive to submit to a medical examination for the purpose of determining Disability shall be deemed to constitute conclusive
evidence of Executive’s Disability. 
 (d) Good Reason. For the sole purpose of determining Executive’s right to severance
payments as described above, Executive’s resignation will be for “Good Reason” if Executive resigns within ninety days after any of the following events, unless Executive consents to the applicable event: (i) a decrease in
Executive’s annual base salary, other than a reduction in annual base salary of less than 10% that is implemented in connection with a contemporaneous reduction in annual base salaries affecting other senior executives of the Company, or
(ii) a material decrease in Executive’s authority or areas of responsibility as are commensurate with Executive’s then title or position (other than in connection with a corporate transaction where Executive continues to hold the
position referenced in Section 1(o) above with respect to the Company’s business, substantially as such business exists prior to the date of consummation of such corporate transaction, but does not hold such position with respect to the
successor corporation). Notwithstanding the foregoing, no Good Reason will have occurred unless and until Executive has: (a) provided the Company, within 60 days of Executive’s knowledge of the occurrence of the facts and circumstances
underlying the Good Reason event, written-notice stating with specificity the applicable facts and circumstances underlying such finding of Good Reason; and (b) provided the Company with an opportunity to cure the same within 30 days after the
receipt of such notice. 
 (e) Person. “Person” shall mean any individual, firm, corporation, partnership, limited liability
company, incorporated or unincorporated association, joint venture, joint stock company, trust, governmental authority or other entity of any kind. 

11. Miscellaneous Provisions. 
 (a)
Governing Law. This Agreement shall be governed, construed, interpreted and enforced in accordance with its express terms, and otherwise in accordance with the substantive laws of the State of New Jersey without reference to the principles of
conflicts of law of the State of New Jersey or any other jurisdiction, and where applicable, the laws of the United States. 
 (b)
Validity. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

  
 10 

 (c) Notices. Any notice, request, claim, demand, document and other communication
hereunder to any Party shall be effective upon receipt (or refusal of receipt) and shall he in writing and delivered personally or sent by facsimile or certified or registered mail, postage prepaid, as follows: 

(i) If to the Company, the Chief Executive Officer at its headquarters, 

(ii) If to Executive, at the last address that the Company has in its personnel records for Executive, or 

(iii) At any other address as any Party shall have specified by notice in writing to the other Party. 

(d) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, but all of
which together will constitute one and the same Agreement. Signatures delivered by facsimile shall be deemed effective for all purposes. 

(e) Entire Agreement. The terms of this Agreement are intended by the Parties to be the final expression of their agreement with respect
to the subject matter hereof and supersede all prior understandings and agreements, whether written or oral. The Parties further intend that this Agreement shall constitute the complete and exclusive statement of their terms and that no extrinsic
evidence whatsoever may be introduced in any judicial, administrative, or other legal proceeding to vary the terms of this Agreement. 
 (f)
Amendments; Waivers. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by Executive and a duly authorized officer of Company. By an instrument in writing similarly executed, Executive or a
duly authorized officer of the Company may waive compliance by the other Party with any specifically identified provision of this Agreement that such other Party was or is obligated to comply with or perform; provided, however, that
such waiver shall not operate as a waiver of, or estoppel with respect to, any other or subsequent failure. No failure to exercise and no delay in exercising any right, remedy, or power hereunder preclude any other or further exercise of any other
right, remedy, or power provided herein or by law or in equity. 
 (g) No Inconsistent Actions. The Parties hereto shall not
voluntarlly undertake or fail to undertake any action of course of action inconsistent with the provisions or essential intent of this Agreement. Furthermore, it is the intent of the Parties hereto to act in a fair and reasonable manner with respect
to the interpretation and application of the provisions of this Agreement. 
 (h) Construction. This Agreement shall be deemed drafted
equally by both the Parties. Its language shall be construed as a whole and according to its fair meaning. Any presumption or principle that the language is to be construed against any Party shall not apply. The headings in this Agreement are only
for convenience and are not intended to affect construction or interpretation, Any references to paragraphs, subparagraphs, sections or subsections are to those parts of this Agreement, unless the context clearly indicates to the contrary. Also,
unless the context clearly indicates to the contrary, (a) the plural includes the singular and the singular includes the plural; (b) “and” and “or” are each used both conjunctively and disjunctively; (c) “any,”
“all,” “each,” or “every” means “any and all,” and “each and every”; (d) “includes” and “including” are each “without limitation”; (e) “herein,”
“hereof,” “hereunder” and other similar compounds of the word “here” refer to the entire Agreement and not to any particular paragraph, subparagraph, section or subsection; and (f) all pronouns and any variations
thereof shall be deemed to refer to the masculine, feminine, neuter, singular or plural as the identity of the entities or persons referred to may require. 

  
 11 

 (i) Arbitration. Any controversy, claim or dispute arising out of or relating to this
Agreement, shall be settled solely and exclusively by a binding arbitration process administered by JAMS/Endispute in New York, New York. Such arbitration shall be conducted in accordance with the then-existing JAMS/Endispute Rules of Practice and
Procedure, with the following exceptions if in conflict: (a) one arbitrator who is a retired judge shall be chosen by JAMS/Endispute; (b) each Party to the arbitration will pay one-half of the
expenses and fees of the arbitrator, together with other expenses of the arbitration incurred or approved by the arbitrator; and (c) arbitration may proceed in the absence of any Party if written notice (pursuant to the JAMS/Endispute rules and
regulations) of the proceedings has been given to such Party. Each Party shall bear its own attorney’s fees and expenses; provided that the arbitrator may assess the prevailing Party’s fees and costs against the non-prevailing Party as part of the arbitrator’s award. The Parties agree to abide by all decisions and awards rendered in such proceedings. Such decisions and awards rendered by the arbitrator shall be final
and conclusive. All such controversies, claims or disputes shall be settled in this manner in lieu of any action at law or equity; provided, however, that nothing in this subsection shall be construed as precluding the bringing an action for
injunctive relief or specific performance as provided in this Agreement. This dispute resolution process and any arbitration hereunder shall be confidential and neither any Party nor the neutral arbitrator shall disclose the existence, contents or
results of such process without the prior written consent of all Parties, except where necessary or compelled in a Court to enforce this arbitration provision or an award from such arbitration or otherwise in a legal proceeding, If JAMS/Endispute no
longer exists or is otherwise unavailable, the Parties agree that the American Arbitration Association (“AAA”) shall administer the arbitration in accordance with its then-existing rules as modified by this subsection. In such
event, all references herein to JAMS/Endispute shall mean AAA. Notwithstanding the foregoing. Executive and the Company each have the right to resolve any issue or dispute over intellectual property rights by Court action instead of arbitration.

 (j) Enforcement. If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws
effective during the term of this Agreement, such provision shall be fully severable; this Agreement shall be construed and enforced as if such illegal, invalid or unenforceable provision had never comprised a portion of this Agreement; and the
remaining provisions of this Agreement shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or
unenforceable provision there shall be added automatically as part of this Agreement a provision as similar in terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable. 

(k) Withholding. The Company shall be entitled to withhold from any amounts payable under this Agreement any federal, state, local or
foreign withholding or other taxes or charges which the Company is required to withhold. The Company shall be entitled to rely on an opinion of counsel if any questions as to the amount or requirement of withholding shall arise. 

(1) Section 409A. 

(i) General. The intent of the Parties is that the payments and benefits under this Agreement comply with or be exempt
from Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (collectively, “Section 409A”) and, accordingly, to the maximum extent permitted,
this Agreement shall be interpreted to be in compliance therewith. 
 (ii) Separation from Service. Notwithstanding
anything in this Agreement to the contrary, any compensation or benefits payable under this Agreement that is considered nonqualified deferred compensation under Section 409A and is designated under this Agreement as payable upon
Executive’s termination of employment shall be payable only upon Executive’s “separation from service” with the Company within the meaning of Section 409A (a “Separation from Service”) and, except as
provided below, any such compensation or benefits described in 

  
 12 

 Section 4(b) shall not be paid, or, in the case of installments, shall not
commence payment, until the thirtieth (30th) day following Executive’s Separation from Service (the “First Payment Date”). Any installment payments that would have been made to Executive during the thirty (30) day period
immediately following Executive’s Separation from Service but for the preceding sentence shall be paid to Executive on the First Payment Date and the remaining payments shall be made as provided in this Agreement. 

(iii) Specified Employee. Notwithstanding anything in this Agreement to the contrary, if Executive is deemed by the
Company at the time of Executive’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this
Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (i) the expiration of the six-month period measured
from the date of Executive’s Separation from Service with the Company or (ii) the date of Executive’s death. Upon the first business day following the expiration of the applicable Section 409A period, all payments deferred
pursuant to the preceding sentence shall be paid in a lump sum to Executive (or Executive’s estate or beneficiaries), and any remaining payments due to Executive under this Agreement shall be paid as otherwise provided herein. 

(iv) Expense Reimbursements. To the extent that any reimbursements under this Agreement are subject to
Section 409A, any such reimbursements payable to Executive shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred; provided, that Executive submits Executive’s
reimbursement request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in
Section 105(b) of the Code, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. 

(v) Installments. Executive’s right to receive any installment payments under this Agreement, including
without limitation any continuation salary payments that are payable on Company payroll dates, shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a
separate and distinct payment as permitted under Section 409A. Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such acceleration or deferral would not result in additional tax
or interest pursuant to Section 409A. 
 12. Executive Acknowledgement. 

Executive acknowledges that Executive has read and understands this Agreement, is fully aware of its legal effect, has not acted in reliance
upon any representations or promises made by the Company other than those contained in writing herein, and has entered into this Agreement freely based on Executive’s own judgment. 

[Signature Page Follows] 

  
 13 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the date and year first
above written. 
  

					
	COMPANY
		
	By:	 	 /s/ RAM JAGANNATH

		 	Name: RAM JAGANNATH
		 	Title:   DIRECTOR	 	
	
	EXECUTIVE
		
	By:	 	 /s/ Michael A. Schlesinger

		 	 Michael A. Schlesinger
	 	

 [Signature Page to Employment Agreement] 

  
 14 

 EXHIBIT A 

Separation Agreement and Release 

This Separation Agreement and Release (“Agreement”) is made by and between
[                     ] (“Executive”) and Crimson Bermuda Co. Ltd. (the “Company”) (collectively,
referred to as the “Parties” or individually referred to as a “Party”). Capitalized terms used but not defined in this Agreement shall have the meanings set forth in the Employment Agreement (as
defined below). 
 WHEREAS, the Parties have previously entered into that certain Employment Agreement, dated as
of                         , 2014 (the “Employment Agreement”); and 

WHEREAS, in connection with Executive’s termination of employment with the Company or a subsidiary or affiliate of the Company
effective                    , 20     , the Parties wish to resolve any and all disputes, claims, complaints,
grievances, charges, actions, petitions, and demands that Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive’s
employment with or separation from the Company or its subsidiaries or affiliates but, for the avoidance of doubt, nothing herein will be deemed to release any rights or remedies in connection with Executive’s ownership of vested equity
securities of the Company or one of its affiliates or Executive’s right to indemnification by the Company or any of its affiliates pursuant to çontract or applicable law (collectively, the “Retained Claims”). 

NOW, THEREFORE, in consideration of the severance payments and benefits described in Section 4(b) of the Employment Agreement, which,
pursuant to the Employment Agreement, are conditioned on Executive’s execution and non-revocation of this Agreement, and in consideration of the mutual promises made herein, the Company and Executive
hereby agree as follows: 
 1. Severance Payments; Salary and Benefits. The Company agrees to provide Executive with the severance
payments and benefits described in Section 4(b) of the Employment Agreement, payable at the times set forth in, and subject to the terms and conditions of the Employment Agreement. In addition, to the extent not already paid, and subject to the
terms and conditions of the Employment Agreement, the Company shall pay or provide to Executive all other payments or benefits described in Section 3(c) of the Employment Agreement, subject to and in accordance with the terms thereof. 

2. Release of Claims. Executive agrees that, other than with respect to the Retained Claims, the foregoing consideration represents
settlement in full of all outstanding obligations owed to Executive by the Company, any of its direct or indirect subsidiaries and affiliates (including, without limitation, TC Group, L.L.C. and its affiliated entities), and any of their current and
former officers, directors, equity holders, managers, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries and predecessor and
successor corporations and assigns (collectively, the “Releasees”). Executive, on his own behalf and on behalf of any of Executive’s affiliated companies or entities and any of their respective heirs, family members, executors,
agents, and assigns, other than with respect to the Retained Claims, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty,
obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have
occurred up until and including the Effective Date of this Agreement (as defined in Section 7 below), including, without limitation: 

(a) any and all claims relating to or arising from Executive’s employment or service relationship with the Company or any of its direct
or indirect subsidiaries or affiliates and the termination of that relationship; 

  
 A-1 

 (b) any and all claims relating to, or arising from, Executive’s right to purchase, or
actual purchase of any shares of stock or other equity interests of the Company or any of its affiliates, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state
corporate law, and securities fraud under any state or federal law; 
 (c) any and all claims for wrongful discharge of employment;
termination in violation of public policy; discrimination; harassment; retaliation, breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or
intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander;
negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits; 
 (d) any and
all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of
1990; the Equal Pay Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the Worker Adjustment and Retraining
Notification Act, the Family and Medical Leave Act; and the Sarbanes-Oxley Act of 2002; 
 (e) any and all claims for violation of the
federal or any state constitution; 
 (f) any and all claims arising out of any other laws and regulations relating to employment or
employment discrimination; 
 (g) any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; and 

(h) any and all claims for attorneys’ fees and costs. 

Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters
released. This release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any
other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that Executive’s release of claims herein bars Executive
from recovering such monetary relief from the Company of any Releasee), claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law, claims to continued participation in certain of
the Company’s group benefit plans pursuant to the terms and conditions of COBRA, claims to any benefit entitlements vested as the date of separation of Executive’s employment, pursuant to written terms of any employee benefit plan of the
Company or its affiliates and Executive’s right under applicable law and any Retained Claims. This release further does not release claims for breach of Section 3(c) or Section 4(b) of the Employment Agreement. 

3. Acknowledgment of Waiver of Claims under ADEA. Executive understands and acknowledges that Executive is waiving and releasing any
rights Executive may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this Waiver and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any
rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of 

  
 A-2 

 value to which Executive was already entitled. Executive further understands and acknowledges that Executive
has been advised by this writing that: (a) Executive should consult with an attorney prior to executing this Agreement; (b) Executive has 21 days within which to consider this Agreement; (c) Executive has 7 days following
Executive’s execution of this Agreement to revoke this Agreement pursuant to written notice to the Chief Executive Officer of the Company; (d) this Agreement shall not be effective until after the revocation period has expired; and
(e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent; penalties, or costs for doing so,
unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company in less than the 21 day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen
to waive the time period allotted for considering this Agreement. 
 4. Severability. In the event that any provision or any portion
of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without
said provision or portion of provision. 
 5. No Oral Modification. This Agreement may only be amended in a writing signed by
Executive and a duly authorized officer of the Company. 
 6. Governing Law; Dispute Resolution. This Agreement shall be subject to
the provisions of Sections 11(a), 11(c) and 11(i) of the Employment Agreement. 
 7. Effective Date. If Executive has attained or is
over the age of 40 as of the date of Executive’s termination of employment, then Executive has seven days after Executive signs this Agreement to revoke it and this Agreement will become effective on the eighth day after Executive signed this
Agreement, so long as it has been signed by the Parties and has not been revoked by Executive before that date (the “Effective Date”). If Executive has not attained the age of 40 as of the date of Executive’s termination of
employment, then the “Effective Date” shall be the date on which Executive signs this Agreement. 
 8. Voluntary Execution of
Agreement. Executive understands and agrees that Executive executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of
Executive’s claims against the Company and any of the other Releasees. Executive acknowledges that: (a) Executive has read this Agreement; (b) Executive has not relied upon any representations or statements made by the Company that
are not specifically set forth in this Agreement; (c) Executive has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his own choice or has elected not to retain legal counsel;
(d) Executive understands the terms and consequences of this Agreement and of the releases it contains; and (e) Executive is fully aware of the legal and binding effect of this Agreement. 

[Signature Page Follows] 

  
 A-3 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates act
forth below. 
  

							
	Dated:                    	 		 	EXECUTIVE
	 	  

		 		 	
			
		 		 	COMPANY
				
	Dated:                     	 		 	By:	 	      

		 		 		 	Name:
		 		 		 	Title:

  
 A-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]